The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study

Vulnerable subjects, including systemic lupus erythematosus (SLE) patients, have been prioritised to receive anti-SARS-CoV-2 vaccines. Few data about the safety of these vaccines in SLE are available. The aim of our study is to investigate the safety of anti-SARS-CoV-2 vaccines in SLE. We included 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerosa, Maria, Schioppo, Tommaso, Argolini, Lorenza Maria, Sciascia, Savino, Ramirez, Giuseppe Alvise, Moroni, Gabriella, Sinico, Renato Alberto, Bonelli, Grazia, Alberici, Federico, Mescia, Federica, Moroni, Luca, Tamborini, Francesco, Miraglia, Paolo, Bellocchi, Chiara, Beretta, Lorenzo, Roccatello, Dario, Dagna, Lorenzo, Bozzolo, Enrica, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146432/
https://www.ncbi.nlm.nih.gov/pubmed/35632419
http://dx.doi.org/10.3390/vaccines10050663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146432/
https://www.ncbi.nlm.nih.gov/pubmed/35632419
http://dx.doi.org/10.3390/vaccines10050663

Ejemplares similares